The role of biologic agents in the management of common shoulder pathologies: current state and future directions

James B. Carr, Scott A. Rodeo

Résultat de rechercheexamen par les pairs

39 Citations (Scopus)

Résumé

The field of orthopedic surgery has seen a rapid increase in the use of various biologic agents for the treatment of common musculoskeletal injuries. Most biologic agents attempt to harness or mimic naturally occurring growth factors, cytokines, and anti-inflammatory mediators to improve tissue healing and recovery. The most commonly used biologic agents are platelet-rich plasma and cells derived from bone marrow aspirate and adipose tissue. These agents have become increasingly popular despite a relative dearth of clinical data to support their use. Much confusion exists among patients and physicians in determining the role of these agents in treating common shoulder pathologies, such as glenohumeral osteoarthritis, rotator cuff tears, and tendinopathy. This article reviews the basic science and clinical evidence for the most commonly used biologic agents in the management of common shoulder pathology.

Langue d'origineEnglish
Pages (de-à)2041-2052
Nombre de pages12
JournalJournal of Shoulder and Elbow Surgery
Volume28
Numéro de publication11
DOI
Statut de publicationPublished - nov. 2019

ASJC Scopus Subject Areas

  • Surgery
  • Orthopedics and Sports Medicine

Empreinte numérique

Plonger dans les sujets de recherche 'The role of biologic agents in the management of common shoulder pathologies: current state and future directions'. Ensemble, ils forment une empreinte numérique unique.

Citer